Navigating the Complexities of International Health Care Compliance in M&A Transactions: An Interactive Benchmarking Session

November 10, 2016

We discussed the many compliance challenges for life sciences companies in today’s active merger environment. Our wide-reaching discussion covered topics such as:

  • Appropriate pre-acquisition due diligence
  • The challenges of integrating two differing compliance programs
  • What’s needed on “Day 1”
  • Scoping and conducting risk assessments post-close 

Click the links below to access the presentation materials.